Skip Nav Destination
1-7 of 7
Joanna Jonska-Gmyrek, Agnieszka Zolciak-Siwinska, Leszek Gmyrek, Wojciech Michalski, Grazyna Poniatowska, Malgorzata Fuksiewicz, Pawel Wiechno, Jakub Kucharz, Maria Kowalska, Beata Kotowicz
Gynecol Obstet Invest (2018) 83 (3): 220–226.
Published Online: 23 January 2018
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Cervical cancer Treatment Histopathology Immunohistochemistry Radiotherapy Oncology p53 Risk factors Targeted...
Gynecol Obstet Invest (2010) 70 (2): 87–90.
Published Online: 10 March 2010
... of ovarian metastases from SCCL may increase in the near future. Case: A 54-year-old woman with SCCL presented with a left ovarian mass, 4.8 cm in diameter. The microscopic appearance of the ovarian tumor was identical to that of the previous bronchoscopic biopsy. Molecular analysis of p53 demonstrated...
Gynecol Obstet Invest (1994) 37 (2): 141–142.
Published Online: 01 March 2010
...J. Dietl; H.-P. Horny; E. Kaiserling The expression of p53 in 7 dysgerminomas of the ovary was investigated immunohistochemically with the monoclonal antibodies DAKO-p53/Do-7 and Dianova-p53/Do-l. All the tumors exhibited overexpression of p53 protein. Immunoreactive tumor cell nuclei amounted...
Hüsnü Gökaslan, Levent Türkeri, Zehra Neşe Kavak, Funda Eren, Alper Şişmanoğlu, Şennur İlvan, Fatih Durmuşoğlu
Gynecol Obstet Invest (2005) 59 (1): 36–40.
Published Online: 07 January 2005
...Hüsnü Gökaslan; Levent Türkeri; Zehra Neşe Kavak; Funda Eren; Alper Şişmanoğlu; Şennur İlvan; Fatih Durmuşoğlu Background/Aim: To investigate the expression and value for diagnosis of the genes, p53 and pTEN, the protein, Ki-67, and the receptors, estrogen and progesterone, in differentiating...
Gynecol Obstet Invest (2000) 49 (4): 266–271.
Published Online: 19 May 2000
...Huey-Yi Chen; Chao-Tien Hsu; Wu-Chou Lin; Horng-Der Tsai; Weng-Cheng Chang The purpose of this retrospective study was to evaluate the patterns of p53 expression in stage IB1 squamous cell carcinoma of the uterine cervix, to compare p53 expression with clinicopathological findings, and to assess...
Gynecol Obstet Invest (2000) 49 (3): 190–193.
Published Online: 05 April 2000
... for human papillomavirus (HPV) typing via polymerase chain reaction, the expression of p53 via immunohistochemical study, and clinical behavior. The prevalence of HPV DNA was higher in the younger group than in the older group (84.0 vs. 50.0%) as was the detection rate of HPV 16 (44.0 vs. 6.3%). In contrast...
Gynecol Obstet Invest (2000) 49 (1): 47–51.
Published Online: 06 January 2000
...T.K.H. Chung; T.H. Cheung; K.F. To; Y.F. Wong Primary fallopian tube carcinoma is a rare form of female cancer and the genetic basis of its carcinogenesis remains unclear. Eighteen cases of primary fallopian tube adenocarcinoma were studied. Immunohistochemical staining for p53, HER-2/ neu and c...